YouTube on MSN

BLUETTI Elite 200 v2 | Crazy efficient 2600w portable solar power station

The Professor reviews Bluetti's new subcompact power saving 2600 watt portable power station / solar generator -- the 2074Wh Elite 200 v2. [BONUS: Includes password to unlock turbo / pro fast charge ...
PC Magazine

Apple's Siri AI Will Automatically Fix Your Weak Passwords. Can You Trust It?

With iOS 27, Apple is using AI to automate the second part. Instead of manually changing the password for each website, you’ll soon be able to visit the Passwords app’s Security tab and let Apple’s AI ...
The New York Times

Tired of Hacked Passwords? Help Is on the Way.

Apps from Apple, Google and others can assist in making your online accounts more secure, even as new ways of logging in continue to take off. By J. D. Biersdorfer J.D. Biersdorfer writes about how to ...
Mashable

Microsoft Edge is storing passwords as plain text? Here's what Microsoft says.

UPDATE: May. 6, 2026, 9:40 a.m. EDT This piece was updated to include a statement from Microsoft. Password managers are supposed to make life easier for users by remembering their passwords and ...
security

Norton Password Manager Review and Pricing in 2026: A Deep Dive by Security Experts

Norton Password Manager is free with unlimited passwords, but lacks desktop apps and data breach notifications. It’s safe but has no third-party audit. We’ve tested countless free password managers ...
MedCity News

Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Bloomberg L.P.

Flagship-Backed Generate Biomedicines Raises $400 Million in IPO

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
The Boston Globe

Flagship-backed Generate Biomedicines seeks $425 million in IPO

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
Gizmodo

AI-Generated Passwords Are Apparently Quite Easy to Crack

The era of AI has not been particularly great for cybersecurity. We know that vibe-coded websites and apps have been a hotbed of security flaws that leave the platforms vulnerable to attacks. It turns ...
Seeking Alpha

Generate Biomedicines Begins IPO Push With Major Collaboration Deals

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
Bloomberg L.P.

Flagship-Backed Drug Firm Generate Biomedicines Files for US IPO

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...